Andres LagunaGlobal Medical Affairs Director, Cardiovascular, Renal & Metabolism at NovartisSpeaker
Agenda Sessions
Addressing Lp(a)-mediated cardiovascular risk: Can RNA-targeting therapies be the answer?
, 13:55View Session